{
 "@context" : "http://schema.org",
  "id" : "http://bio2rdf.org/drugbank:DB00236",
  "type" : "Drug",
  "clinicalPharmacology" : "Pipobroman is an antineoplastic agent. Specifically it is a piperazine derivative with a chemical structure close to that of many DNA alkylating agents. Pipobroman has well documented clinical activity against polycythemia vera and essential thrombocythemia.",
  "description" : "An antineoplastic agent that acts by alkylation. [PubChem]",
  "schema:identifier" : "drugbank:DB00236",
  "legalStatus" : "Approved",
  "manufacturer" : {
    "id" : "http://bio2rdf.org/drugbank_resource:d4eb3451ac96e7e3ee0aadeafce55aca",
    "type" : "Organization",
    "name" : "Abbott laboratories pharmaceutical products div"
  },
  "mechanismOfAction" : "The mechanism of action is uncertain but pipobroman is thought to alkylate DNA leading to disruption of DNA synthesis and eventual cell death.",
  "name" : "Pipobroman",
  "nonProprietaryName" : "Vercyte",
  "proprietaryName" : "Vercite",
  "sameAs" : "http://www.drugbank.ca/drugs/DB00236",
  "schema:url" : "http://bio2rdf.org/drugbank:DB00236"
}